Brevan Howard Capital Management’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,918
Closed -$69.4K 1303
2024
Q1
$69.4K Buy
+14,918
New +$69.4K ﹤0.01% 874